EcoR1 Capital’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,249,812
| Closed | -$25.2M | – | 91 |
|
|
2021
Q3 | $25.2M | Buy |
+1,249,812
| New | +$34.5M | 0.88% | 22 |
|
|
2020
Q3 | – | Sell |
-2,721,993
| Closed | -$69.1M | – | 64 |
|
|
2020
Q2 | $69.1M | Sell |
2,721,993
-624,308
| -19% | -$13.4M | 5.11% | 7 |
|
|
2020
Q1 | $61.5M | Sell |
3,346,301
-281,296
| -8% | -$5.47M | 6.42% | 4 |
|
|
2019
Q4 | $79.9M | Sell |
3,627,597
-335,381
| -8% | -$6.75M | 7.2% | 3 |
|
|
2019
Q3 | $56.9M | Buy |
3,962,978
+646,571
| +19% | +$9.24M | 7.19% | 6 |
|
|
2019
Q2 | $52.2M | Hold |
3,316,407
| – | – | 5.28% | 8 |
|
|
2019
Q1 | $48.6M | Hold |
3,316,407
| – | – | 4.48% | 9 |
|
|
2018
Q4 | $35.5M | Sell |
3,316,407
-485,920
| -13% | -$6.39M | 3.55% | 11 |
|
|
2018
Q3 | $58M | Buy |
3,802,327
+841,180
| +28% | +$12.2M | 5.23% | 7 |
|
|
2018
Q2 | $36.3M | Sell |
2,961,147
-1,803,300
| -38% | -$22.7M | 3.45% | 9 |
|
|
2018
Q1 | $45.5M | Sell |
4,764,447
-72,100
| -1% | -$777K | 4.57% | 8 |
|
|
2017
Q4 | $43.7M | Buy |
4,836,547
+3,878,555
| +405% | +$28.5M | 4.92% | 7 |
|
|
2017
Q3 | $5.51M | Buy |
957,992
+190,000
| +25% | +$691K | 0.73% | 24 |
|
|
2017
Q2 | $2.44M | Buy |
767,992
+385,992
| +101% | +$1.22M | 0.43% | 26 |
|
|
2017
Q1 | $1.3M | Buy |
+382,000
| New | +$1.08M | 0.33% | 24 |
|
Other funds holding DRNA
EcoR1 Capital's DRNA Position: Q4 2021 in Review
EcoR1 Capital sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 1,249,812 shares — an estimated $25.2M sold.
EcoR1 Capital first reported a position in DRNA in Q1 2017 and held it in 15 quarters. The position peaked at $79.9M in Q4 2019. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- EcoR1 Capital reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- EcoR1 Capital sold 1,249,812 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $25.2M.
- EcoR1 Capital first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2017 and held it in 15 quarters.
- EcoR1 Capital's Dicerna Pharmaceuticals, Inc. position peaked at $79.9M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on EcoR1 Capital's 13F filing for Q4 2021, filed 14 Feb 2022.